亚胺培南的抗生素后效应：与药物浓度、暴露时间及最低抑菌浓度的关系
The postantibiotic effect of imipenem: relationship with drug concentration, duration of exposure, and MIC.
作者信息
Munckhof W J, Olden D, Turnidge J D
机构信息
Department of Infectious Diseases and Clinical Epidemiology, Monash Medical Centre, Melbourne, Victoria, Australia.
出版信息
Antimicrob Agents Chemother. 1997 Aug;41(8):1735-7. doi: 10.1128/AAC.41.8.1735.
Abstract
The postantibiotic effect (PAE) of imipenem against Escherichia coli was measured at a wide variety of drug concentrations and times of exposure. We observed that the area under the concentration-time curve of drug exposure (AUC), the product of time of exposure and concentration of drug, is a much better predictor of the duration of the PAE than either parameter alone. We also measured the PAE of imipenem against strains of gram-positive and gram-negative bacteria for which MICs varied widely. The E50, the AUC required to produce 50% of the maximum PAE, is correlated with the MIC and is independent of species. This may explain why the duration of the PAE differs for bacteria of the same species for which MICs are different.
摘要
在多种药物浓度和暴露时间下测定了亚胺培南对大肠杆菌的抗生素后效应（PAE）。我们观察到，药物暴露的浓度-时间曲线下面积（AUC），即暴露时间与药物浓度的乘积，比单独的任何一个参数都更能预测PAE的持续时间。我们还测定了亚胺培南对最低抑菌浓度（MIC）差异很大的革兰氏阳性菌和革兰氏阴性菌菌株的PAE。产生最大PAE的50%所需的AUC即E50，与MIC相关且与菌种无关。这可能解释了为什么同一菌种中MIC不同的细菌其PAE持续时间也不同。
相似文献
1
The postantibiotic effect of imipenem: relationship with drug concentration, duration of exposure, and MIC.
Antimicrob Agents Chemother. 1997 Aug;41(8):1735-7. doi: 10.1128/AAC.41.8.1735.
2
The postantibiotic effect of meropenem and imipenem on selected bacteria.
J Antimicrob Chemother. 1989 Sep;24 Suppl A:225-31. doi: 10.1093/jac/24.suppl_a.225.
3
Comparative in vitro pharmacodynamics of imipenem and meropenem against ATCC strains of Escherichia coli, Staphylococcus aureus and Bacteroides fragilis.
Diagn Microbiol Infect Dis. 2001 Jan;39(1):39-47. doi: 10.1016/s0732-8893(00)00219-4.
4
Postantibiotic effect of imipenem on gram-positive and gram-negative micro-organisms.
J Antimicrob Chemother. 1986 Dec;18 Suppl E:47-59. doi: 10.1093/jac/18.supplement_e.47.
5
[Effect of superinhibitory levels of imipenem and amikacin singly or in combination on Pseudomonas aeruginosa].
Epidemiol Mikrobiol Imunol. 1997 Dec;46(4):155-7.
6
Isolation and in-vitro and in-vivo characterisation of a mutant of Pseudomonas aeruginosa PAO1 that exhibited a reduced postantibiotic effect in response to imipenem.
J Antimicrob Chemother. 1994 Oct;34(4):485-505. doi: 10.1093/jac/34.4.485.
7
A comparison of the in vitro postantibiotic effect of meropenem and imipenem versus selected enterobacteriaceae and other pathogens.
Diagn Microbiol Infect Dis. 1993 Jul;17(1):71-3. doi: 10.1016/0732-8893(93)90074-h.
8
Pharmacodynamics of meropenem and imipenem against Enterobacteriaceae, Acinetobacter baumannii, and Pseudomonas aeruginosa.
Pharmacotherapy. 2004 Jan;24(1):8-15. doi: 10.1592/phco.24.1.8.34804.
9
Studies on the postantibiotic effect and the postantibiotic sub-MIC effect of meropenem.
J Antimicrob Chemother. 1993 Jun;31(6):881-92. doi: 10.1093/jac/31.6.881.
10
Postantibiotic effect of imipenem, alone and in combination with amikacin, on Pseudomonas aeruginosa.
Chemotherapy. 1995 Nov-Dec;41(6):433-6. doi: 10.1159/000239379.
引用本文的文献
1
In Vitro and In Vivo Effect of Amikacin and Imipenem Combinations against Multidrug-Resistant .
Trop Med Infect Dis. 2022 Oct 2;7(10):281. doi: 10.3390/tropicalmed7100281.
2
Pharmacodynamics of the antibacterial effect and emergence of resistance to tomopenem, formerly RO4908463/CS-023, in an in vitro pharmacokinetic model of Staphylococcus aureus infection.
Antimicrob Agents Chemother. 2008 Apr;52(4):1401-6. doi: 10.1128/AAC.01153-07. Epub 2008 Jan 28.
3
Ertapenem: a review of its use in the management of bacterial infections.
Drugs. 2003;63(17):1855-78. doi: 10.2165/00003495-200363170-00006.
4
Postantibiotic effect and delay of regrowth in strains carrying mutations that save proteins or RNA.
Antimicrob Agents Chemother. 2002 Dec;46(12):4022-5. doi: 10.1128/AAC.46.12.4022-4025.2002.
5
In vitro pharmacodynamic properties of colistin and colistin methanesulfonate against Pseudomonas aeruginosa isolates from patients with cystic fibrosis.
Antimicrob Agents Chemother. 2001 Mar;45(3):781-5. doi: 10.1128/AAC.45.3.781-785.2001.
6
Comparative pharmacokinetics of the carbapenems: clinical implications.
Clin Pharmacokinet. 2000 Sep;39(3):185-201. doi: 10.2165/00003088-200039030-00002.
7
Postantibiotic suppression of growth of erythromycin A-susceptible and -resistant gram-positive bacteria by the ketolides telithromycin (HMR 3647) and HMR 3004.
Antimicrob Agents Chemother. 2000 Jun;44(6):1749-53. doi: 10.1128/AAC.44.6.1749-1753.2000.
本文引用的文献
1
Postantibiotic suppression of bacterial growth.
Rev Infect Dis. 1981 Jan-Feb;3(1):28-37. doi: 10.1093/clinids/3.1.28.
2
Ampicillin susceptibility and ampicillin-induced killing rate of Escherichia coli.
Antimicrob Agents Chemother. 1982 Sep;22(3):386-90. doi: 10.1128/AAC.22.3.386.
3
Postantibiotic effect of imipenem on Pseudomonas aeruginosa.
Antimicrob Agents Chemother. 1984 Nov;26(5):678-82. doi: 10.1128/AAC.26.5.678.
4
Postantibiotic effect of roxithromycin, erythromycin, and clindamycin against selected gram-positive bacteria and Haemophilus influenzae.
J Antimicrob Chemother. 1987 Nov;20 Suppl B:39-46. doi: 10.1093/jac/20.suppl_b.39.
5
Correlation of antimicrobial pharmacokinetic parameters with therapeutic efficacy in an animal model.
J Infect Dis. 1988 Oct;158(4):831-47. doi: 10.1093/infdis/158.4.831.
6
Comparative antibiotic dose-effect relations at several dosing intervals in murine pneumonitis and thigh-infection models.
J Infect Dis. 1989 Feb;159(2):281-92. doi: 10.1093/infdis/159.2.281.
7
Pharmacodynamics of beta-lactam antibiotics on gram-negative bacteria: initial killing, morphology and postantibiotic effect.
Scand J Infect Dis Suppl. 1990;74:118-23.
8
Prediction of antibiotic dosing intervals from in vitro susceptibility, pharmacokinetics and post-antibiotic effect: theoretical considerations.
Scand J Infect Dis Suppl. 1990;74:137-41.
9
Evaluation of the E test, a novel method of quantifying antimicrobial activity.
J Antimicrob Chemother. 1991 Feb;27(2):185-90. doi: 10.1093/jac/27.2.185.
10
Persistent effect of antibiotics on Staphylococcus aureus after exposure for limited periods of time.
J Infect Dis. 1977 Feb;135(2):217-23. doi: 10.1093/infdis/135.2.217.
Zotero 插件